HDL-C | |||||
 | Q1 | Q2 | Q3 | Q4 | P for trend |
(n = 145) | (n = 151) | (n = 132) | (n = 143) | ||
Death rates, % | 25.5 | 34.4 | 29.5 | 29.4 | 0.65 |
Hazard ratio for total mortality, 95 % CI | 1 | 1.42 (0.93–2.17) | 1.18 (0.75–1.84) | 1.18 (0.76–1.83) | 0.72 |
Hazard ratio for cardiovascular mortality, 95 % CI | 1 | 1.45 (0.88–2.57) | 1.12 (0.60–2.07) | 0.95 (0.50–1.80) | 0.67 |
IF1 | |||||
 | Q1 | Q2 | Q3 | Q4 | P for trend |
(n = 147) | (n = 141) | (n = 145) | (n = 144) | ||
Death rates, % | 36.7 | 31.2 | 26.9 | 22.9 | 0.007 |
Death rate per-person years, number of deaths per 1000 person-years | 38.8 | 32.2 | 27.2 | 23.2 | 0.007 |
Hazard ratio for total mortality, 95 % CI | 1 | 0.83 (0.56–1.23) | 0.69 (0.45–1.04) | 0.55 (0.38–0.89) | 0.008 |
Hazard ratio for cardiovascular mortality, 95 % CI | 1 | 0.51 (0.28–0.94) | 0.65 (0.38–1.12) | 0.50 (0.28–0.89) | 0.03 |
Hazard ratio for cancer mortality, 95 % CI | 1 | 1.24 (0.51–2.99) | 0.53 (0.18–1.57) | 0.53 (0.18–1.58) | 0.12 |